Evaluation of PDZD11 in hepatocellular carcinoma: prognostic value and diagnostic potential in combination with AFP

Evaluation of PDZD11 in hepatocellular carcinoma: prognostic value and diagnostic potential in combination with AFP

BackgroundHepatocellular carcinoma (HCC) is the most prevalent liver cancer, with a 5-year survival rate below 20% and an average survival time of 3-6 months. Identifying new biomarkers is crucial for early diagnosis and prognosis. The function of PDZ domain protein 11 (PDZD11) in HCC remains unclea...

Full description

Saved in:
Bibliographic Details
Main Authors: Yiyun Ni, Bin Liu, Weizhen Zhang, Yilin Pang, Yaling Tian, Qingsong Lv, Shengwen Shi, Yang Zheng, Huihui Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
PDZD11
AFP
serological biomarker
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1533865/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1533865/full

Similar Items